Correlation Between Viemed Healthcare and Tscan Therapeutics
Can any of the company-specific risk be diversified away by investing in both Viemed Healthcare and Tscan Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viemed Healthcare and Tscan Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viemed Healthcare and Tscan Therapeutics, you can compare the effects of market volatilities on Viemed Healthcare and Tscan Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viemed Healthcare with a short position of Tscan Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viemed Healthcare and Tscan Therapeutics.
Diversification Opportunities for Viemed Healthcare and Tscan Therapeutics
-0.3 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Viemed and Tscan is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Viemed Healthcare and Tscan Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tscan Therapeutics and Viemed Healthcare is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viemed Healthcare are associated (or correlated) with Tscan Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tscan Therapeutics has no effect on the direction of Viemed Healthcare i.e., Viemed Healthcare and Tscan Therapeutics go up and down completely randomly.
Pair Corralation between Viemed Healthcare and Tscan Therapeutics
Considering the 90-day investment horizon Viemed Healthcare is expected to under-perform the Tscan Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Viemed Healthcare is 2.3 times less risky than Tscan Therapeutics. The stock trades about -0.09 of its potential returns per unit of risk. The Tscan Therapeutics is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest 489.00 in Tscan Therapeutics on August 29, 2024 and sell it today you would lose (25.00) from holding Tscan Therapeutics or give up 5.11% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Viemed Healthcare vs. Tscan Therapeutics
Performance |
| Timeline |
| Viemed Healthcare |
| Tscan Therapeutics |
Viemed Healthcare and Tscan Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Viemed Healthcare and Tscan Therapeutics
The main advantage of trading using opposite Viemed Healthcare and Tscan Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viemed Healthcare position performs unexpectedly, Tscan Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tscan Therapeutics will offset losses from the drop in Tscan Therapeutics' long position.The idea behind Viemed Healthcare and Tscan Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Tscan Therapeutics vs. Apellis Pharmaceuticals | Tscan Therapeutics vs. Iteos Therapeutics | Tscan Therapeutics vs. Day One Biopharmaceuticals | Tscan Therapeutics vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |